The University of Chicago Header Logo

Connection

Katharine Yao to Female

Back to Details
This is a "connection" page, showing publications Katharine Yao has written about Female.
Katharine Yao
Connection Strength
1.993
Female
  1. Patient values in breast cancer surgical decision-making - The WhySurg study. Am J Surg. 2024 Jan; 227:137-145.
    View in: PubMed
    Score: 0.046
  2. Trends in bilateral mastectomy rates among different racial backgrounds: A National Cancer Database study. Am J Surg. 2023 10; 226(4):455-462.
    View in: PubMed
    Score: 0.045
  3. Rates of Bilateral Mastectomy in Patients With Early-Stage Breast Cancer. JAMA Netw Open. 2023 01 03; 6(1):e2251348.
    View in: PubMed
    Score: 0.044
  4. Impact of Surgical Delay on Tumor Upstaging and Outcomes in Estrogen Receptor-Negative Ductal Carcinoma in Situ Patients. J Am Coll Surg. 2022 11 01; 235(5):788-798.
    View in: PubMed
    Score: 0.043
  5. Male Breast Cancer Patient and Surgeon Experience: The Male WhySurg Study. Ann Surg Oncol. 2022 Oct; 29(10):6115-6131.
    View in: PubMed
    Score: 0.042
  6. ASO Visual Abstract: Improving the Breast Surgeon's Ergonomic Workload for Nipple-Sparing Mastectomies Using Exercise and an Operating Room Positioning Protocol. Ann Surg Oncol. 2022 06; 29(6):3863.
    View in: PubMed
    Score: 0.042
  7. Patients Undergoing Bilateral Mastectomy and Breast-Conserving Surgery Have the Lowest Levels of Regret: The WhySurg Study. Ann Surg Oncol. 2021 Oct; 28(10):5686-5697.
    View in: PubMed
    Score: 0.040
  8. Improving the Breast Surgeon's Ergonomic Workload for Nipple-Sparing Mastectomies Using Exercise and Operating Room Positioning Protocol. Ann Surg Oncol. 2021 Oct; 28(10):5698-5706.
    View in: PubMed
    Score: 0.040
  9. Covid-19 related oncologist's concerns about breast cancer treatment delays and physician well-being (the CROWN study). Breast Cancer Res Treat. 2021 Apr; 186(3):625-635.
    View in: PubMed
    Score: 0.038
  10. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat. 2020 Jun; 181(3):487-497.
    View in: PubMed
    Score: 0.036
  11. Differences in physician opinions about controversial issues surrounding contralateral prophylactic mastectomy (CPM): A survey of physicians from accredited breast centers in the United States. Cancer Med. 2020 05; 9(9):3088-3096.
    View in: PubMed
    Score: 0.036
  12. An In-Visit Decision Aid for Surgeons to Address Decision Making for Bilateral Mastectomy for Newly Diagnosed Breast Cancer Patients. Ann Surg Oncol. 2019 Dec; 26(13):4372-4380.
    View in: PubMed
    Score: 0.035
  13. Are we Overtreating Hormone Receptor Positive Breast Cancer with Neoadjuvant Chemotherapy? Role of OncotypeDx® for Hormone Receptor Positive Patients Undergoing Neoadjuvant Chemotherapy. Ann Surg Oncol. 2019 Oct; 26(10):3232-3239.
    View in: PubMed
    Score: 0.034
  14. The "Nipple Whipple"?! A Pilot Study to Assess the Ergonomic Effects of Nipple-Sparing Mastectomy. Ann Surg Oncol. 2019 Oct; 26(10):3216-3223.
    View in: PubMed
    Score: 0.034
  15. Impact of the Society of Surgical Oncology-American Society for Radiation Oncology Margin Guidelines on Breast-Conserving Surgery and Mastectomy Trends. J Am Coll Surg. 2019 07; 229(1):104-114.
    View in: PubMed
    Score: 0.034
  16. ASO Author Reflections: Breast Center Accreditation and Performance: Impact on Patient Care? Ann Surg Oncol. 2019 May; 26(5):1212-1213.
    View in: PubMed
    Score: 0.033
  17. Intact Excision of Breast Lesions Using BLES™: Is There a Clinical Indication Yet? Ann Surg Oncol. 2019 Apr; 26(4):933-935.
    View in: PubMed
    Score: 0.033
  18. Impact of Breast Center Accreditation on Compliance with Breast Quality Performance Measures at Commission on Cancer-Accredited Centers. Ann Surg Oncol. 2019 May; 26(5):1202-1211.
    View in: PubMed
    Score: 0.033
  19. Treatment delays from transfers of care and their impact on breast cancer quality measures. Breast Cancer Res Treat. 2019 Feb; 173(3):603-617.
    View in: PubMed
    Score: 0.033
  20. 'Nudging' Surgeons and Patients to De-Escalation of Surgery for Breast Cancer. Ann Surg Oncol. 2018 Oct; 25(10):2777-2780.
    View in: PubMed
    Score: 0.032
  21. Regional Variation in Performance for Commission on Cancer Breast Quality Measures and Impact on Overall Survival. Ann Surg Oncol. 2018 Oct; 25(10):3069-3075.
    View in: PubMed
    Score: 0.032
  22. Axillary Surgery for Early-Stage, Node-Positive Mastectomy Patients and the Use of Postmastectomy Chest Wall Radiation Therapy. Ann Surg Oncol. 2018 Aug; 25(8):2220-2228.
    View in: PubMed
    Score: 0.031
  23. The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy. Ann Surg Oncol. 2018 Jan; 25(1):164-172.
    View in: PubMed
    Score: 0.031
  24. A Single Institution Retrospective Comparison Study of Locoregional Recurrence After Accelerated Partial Breast Irradiation Using External Beam Fractionation Compared with Whole Breast Irradiation with 8 Years of Follow-Up. Ann Surg Oncol. 2017 Oct; 24(10):2935-2942.
    View in: PubMed
    Score: 0.030
  25. The Impact of Facility Volume on Rates of Pathologic Complete Response to Neoadjuvant Chemotherapy Used in Breast Cancer. Ann Surg Oncol. 2017 Oct; 24(11):3157-3166.
    View in: PubMed
    Score: 0.030
  26. Clinical accuracy of preoperative breast MRI for breast cancer. J Surg Oncol. 2017 Jun; 115(8):924-931.
    View in: PubMed
    Score: 0.029
  27. Are the ACOSOG Z0011 Trial Findings Being Applied to Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy? Breast J. 2017 Sep; 23(5):554-562.
    View in: PubMed
    Score: 0.029
  28. Post-mastectomy radiation therapy and overall survival after neoadjuvant chemotherapy. J Surg Oncol. 2017 May; 115(6):668-676.
    View in: PubMed
    Score: 0.029
  29. National Accreditation Program for Breast Centers Demonstrates Improved Compliance with Post-Mastectomy Radiation Therapy Quality Measure. J Am Coll Surg. 2017 Mar; 224(3):236-244.
    View in: PubMed
    Score: 0.029
  30. Impact of an In-visit Decision Aid on Patient Knowledge about Contralateral Prophylactic Mastectomy: A Pilot Study. Ann Surg Oncol. 2017 Jan; 24(1):91-99.
    View in: PubMed
    Score: 0.028
  31. Trends and variation in the use of nipple-sparing mastectomy for breast cancer in the United States. Breast Cancer Res Treat. 2016 11; 160(1):111-120.
    View in: PubMed
    Score: 0.028
  32. Contralateral Prophylactic Mastectomy Consensus Statement from the American Society of Breast Surgeons: Additional Considerations and a Framework for Shared Decision Making. Ann Surg Oncol. 2016 10; 23(10):3106-11.
    View in: PubMed
    Score: 0.028
  33. Surgeons' Perspectives of Contralateral Prophylactic Mastectomy. Ann Surg Oncol. 2016 09; 23(9):2779-87.
    View in: PubMed
    Score: 0.028
  34. Survey of the Deficits in Surgeons' Knowledge of Contralateral Prophylactic Mastectomy. JAMA Surg. 2016 Apr; 151(4):391-3.
    View in: PubMed
    Score: 0.027
  35. Nipple-sparing mastectomy: A contemporary perspective. J Surg Oncol. 2016 Jun; 113(8):883-90.
    View in: PubMed
    Score: 0.027
  36. Surgery and hormone therapy trends in octogenarians with invasive breast cancer. Am J Surg. 2016 Mar; 211(3):541-5.
    View in: PubMed
    Score: 0.027
  37. Increased utilization of postmastectomy radiotherapy in the United States from 2003 to 2011 in patients with one to three tumor positive nodes. J Surg Oncol. 2015 Dec; 112(8):809-14.
    View in: PubMed
    Score: 0.027
  38. Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups. Breast Cancer Res Treat. 2015 Nov; 154(1):81-8.
    View in: PubMed
    Score: 0.026
  39. Survival Outcomes and Pathologic Features Among Breast Cancer Patients Who Have Developed a Contralateral Breast Cancer. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S412-21.
    View in: PubMed
    Score: 0.026
  40. Clinicopathologic features and time interval analysis of contralateral breast cancers. Surgery. 2015 Sep; 158(3):676-85.
    View in: PubMed
    Score: 0.026
  41. Variation in Contralateral Prophylactic Mastectomy Rates According to Racial Groups in Young Women with Breast Cancer, 1998 to 2011: A Report from the National Cancer Data Base. J Am Coll Surg. 2015 Jul; 221(1):187-96.
    View in: PubMed
    Score: 0.026
  42. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes. Ann Surg Oncol. 2015 Dec; 22(13):4295-304.
    View in: PubMed
    Score: 0.026
  43. Impact of the American College of Surgeons Oncology Group Z0011 Randomized Trial on the Number of Axillary Nodes Removed for Patients with Early-Stage Breast Cancer. J Am Coll Surg. 2015 Jul; 221(1):71-81.
    View in: PubMed
    Score: 0.026
  44. The quality-of-life benefits of breast reconstruction do not diminish with age. J Surg Oncol. 2015 May; 111(6):663-8.
    View in: PubMed
    Score: 0.025
  45. Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the National Cancer Data Base, 2004-2010. JAMA Surg. 2014 Dec; 149(12):1296-305.
    View in: PubMed
    Score: 0.025
  46. Wait times for breast surgical operations, 2003-2011: a report from the National Cancer Data Base. Ann Surg Oncol. 2015 Mar; 22(3):899-907.
    View in: PubMed
    Score: 0.025
  47. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer. Ann Surg Oncol. 2014 Oct; 21(10):3231-9.
    View in: PubMed
    Score: 0.024
  48. Nipple-sparing mastectomy in BRCA1/2 mutation carriers: an interim analysis and review of the literature. Ann Surg Oncol. 2015 Feb; 22(2):370-6.
    View in: PubMed
    Score: 0.024
  49. Utilization of accelerated partial breast irradiation for ductal carcinoma in situ, 2003-2011: report from the national cancer database. Ann Surg Oncol. 2014 Oct; 21(11):3457-65.
    View in: PubMed
    Score: 0.024
  50. Impact of bilateral versus unilateral mastectomy on short term outcomes and adjuvant therapy, 2003-2010: a report from the National Cancer Data Base. Ann Surg Oncol. 2014 Sep; 21(9):2920-7.
    View in: PubMed
    Score: 0.024
  51. Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base. J Am Coll Surg. 2014 Jul; 219(1):19-28.
    View in: PubMed
    Score: 0.024
  52. Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998-2002. Breast Cancer Res Treat. 2013 Dec; 142(3):465-76.
    View in: PubMed
    Score: 0.023
  53. Axillary surgery among estrogen receptor positive women 70 years of age or older with clinical stage I breast cancer, 2004-2010: a report from the National Cancer Data Base. Ann Surg Oncol. 2013 Oct; 20(10):3259-65.
    View in: PubMed
    Score: 0.023
  54. Accelerated partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer patients undergoing breast conservation, 2003-2010: a report from the national cancer data base. Ann Surg Oncol. 2013 Oct; 20(10):3223-32.
    View in: PubMed
    Score: 0.023
  55. Operative risks associated with contralateral prophylactic mastectomy: a single institution experience. Ann Surg Oncol. 2013 Dec; 20(13):4113-20.
    View in: PubMed
    Score: 0.023
  56. Have we expanded the equitable delivery of postmastectomy breast reconstruction in the new millennium? Evidence from the national cancer data base. J Am Coll Surg. 2012 Nov; 215(5):658-66; discussion 666.
    View in: PubMed
    Score: 0.021
  57. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007. Ann Surg Oncol. 2010 Oct; 17(10):2554-62.
    View in: PubMed
    Score: 0.018
  58. Notch-1 and notch-4 receptors as prognostic markers in breast cancer. Int J Surg Pathol. 2011 Oct; 19(5):607-13.
    View in: PubMed
    Score: 0.018
  59. Malignant-appearing microcalcifications at the lumpectomy site with the use of FloSeal hemostatic sealant. AJR Am J Roentgenol. 2008 Nov; 191(5):1371-3.
    View in: PubMed
    Score: 0.016
  60. Histopathologic characteristics of the primary tumor in breast cancer patients with isolated tumor cells of the sentinel node. Surgery. 2008 Oct; 144(4):518-24; discussion 524.
    View in: PubMed
    Score: 0.016
  61. Predicting cancer on excision of atypical ductal hyperplasia. Am J Surg. 2008 Mar; 195(3):358-61; discussion 361-2.
    View in: PubMed
    Score: 0.016
  62. Is sentinel lymph node mapping indicated for isolated local and in-transit recurrent melanoma? Ann Surg. 2003 Nov; 238(5):743-7.
    View in: PubMed
    Score: 0.012
  63. Exploring Breast Surgeons' Attitudes on Universal Genetic Testing: A Qualitative Study. Ann Surg Oncol. 2023 Oct; 30(10):6108-6116.
    View in: PubMed
    Score: 0.011
  64. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic. Cancer. 2022 06 01; 128(11):2119-2125.
    View in: PubMed
    Score: 0.010
  65. Uptake of Breast Cancer Clinical Trials at Minority Serving Cancer Centers. Ann Surg Oncol. 2021 Sep; 28(9):4995-5004.
    View in: PubMed
    Score: 0.010
  66. Patient-reported outcomes among women with unilateral breast cancer undergoing breast conservation versus single or double mastectomy. Breast Cancer Res Treat. 2021 Jan; 185(2):359-369.
    View in: PubMed
    Score: 0.009
  67. Physician Knowledge of Breast Cancer Recurrence and Contralateral Breast Cancer Risk is Associated with Increased Recommendations for Contralateral Prophylactic Mastectomy: a Survey of Physicians at NAPBC-Accredited Centers. Ann Surg Oncol. 2019 Oct; 26(10):3080-3088.
    View in: PubMed
    Score: 0.009
  68. The effect of contralateral prophylactic mastectomy on breast-related charges: A 5-year analysis. J Surg Oncol. 2018 Jul; 118(1):212-220.
    View in: PubMed
    Score: 0.008
  69. Facility-level analysis of robot utilization across disciplines in the National Cancer Database. J Robot Surg. 2019 Apr; 13(2):293-299.
    View in: PubMed
    Score: 0.008
  70. Patient-Reported Outcomes for Breast Cancer. Ann Surg Oncol. 2018 Oct; 25(10):2839-2845.
    View in: PubMed
    Score: 0.008
  71. The Changing Paradigms for Breast Cancer Surgery: Performing Fewer and Less-Invasive Operations. Ann Surg Oncol. 2018 Oct; 25(10):2807-2812.
    View in: PubMed
    Score: 0.008
  72. A Predictive Model for Axillary Node Pathologic Complete Response after Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg Oncol. 2018 May; 25(5):1304-1311.
    View in: PubMed
    Score: 0.008
  73. Risk of Development of Second Primary Head and Neck Cancer following an Index Breast Cancer. Otolaryngol Head Neck Surg. 2018 02; 158(2):303-308.
    View in: PubMed
    Score: 0.008
  74. Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States. JAMA Oncol. 2017 Jul 01; 3(7):928-935.
    View in: PubMed
    Score: 0.007
  75. Utilization trend and regimens of hypofractionated whole breast radiation therapy in the United States. Breast Cancer Res Treat. 2017 04; 162(2):317-328.
    View in: PubMed
    Score: 0.007
  76. Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks. Ann Surg Oncol. 2016 10; 23(10):3100-5.
    View in: PubMed
    Score: 0.007
  77. Patient satisfaction with nipple-sparing mastectomy: A prospective study of patient reported outcomes using the BREAST-Q. J Surg Oncol. 2016 Sep; 114(4):416-22.
    View in: PubMed
    Score: 0.007
  78. Utilization of Axillary Surgery for Patients With Ductal Carcinoma In Situ: A Report From the National Cancer Data Base. Ann Surg Oncol. 2016 10; 23(10):3337-46.
    View in: PubMed
    Score: 0.007
  79. Advanced Age Does Not Worsen Recovery or Long-Term Morbidity After Postmastectomy Breast Reconstruction. Ann Plast Surg. 2016 Feb; 76(2):164-9.
    View in: PubMed
    Score: 0.007
  80. The Effect of Contralateral Prophylactic Mastectomy on Perioperative Complications in Women Undergoing Immediate Breast Reconstruction: A NSQIP Analysis. Ann Surg Oncol. 2015 Oct; 22(11):3474-80.
    View in: PubMed
    Score: 0.006
  81. A Contemporary Analysis of Surgical Trends in the Treatment of Squamous Cell Carcinoma of the Oropharynx from 1998 to 2012: A Report from the National Cancer Database. Ann Surg Oncol. 2015 Dec; 22(13):4422-31.
    View in: PubMed
    Score: 0.006
  82. Advanced age is a predictor of 30-day complications after autologous but not implant-based postmastectomy breast reconstruction. Plast Reconstr Surg. 2015 Feb; 135(2):253e-261e.
    View in: PubMed
    Score: 0.006
  83. Peritumoral expression of adipokines and fatty acids in breast cancer. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S731-8.
    View in: PubMed
    Score: 0.006
  84. Comparison of molecular subtyping with BluePrint, MammaPrint, and TargetPrint to local clinical subtyping in breast cancer patients. Ann Surg Oncol. 2012 Oct; 19(10):3257-63.
    View in: PubMed
    Score: 0.005
  85. Who should have or not have an axillary node dissection with breast cancer? Adv Surg. 2012; 46:1-18.
    View in: PubMed
    Score: 0.005
  86. Needle versus excisional biopsy for noninvasive and invasive breast cancer: report from the National Cancer Data Base, 2003-2008. Ann Surg Oncol. 2011 Dec; 18(13):3802-10.
    View in: PubMed
    Score: 0.005
  87. Sentinel node biopsy alone for node-positive breast cancer: 12-year experience at a single institution. J Am Coll Surg. 2011 Jul; 213(1):122-8; discussion 128-9.
    View in: PubMed
    Score: 0.005
  88. Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res. 2008 Jul 01; 68(13):5226-35.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.